FindTrial
Sign In

Evaluation of Unani formulation in patients of Urinary Tract Infection

Efficacy of Qurs-e-kakanaj in Tadiya majrae baul (Urinary Tract Infection)- A single blind randomised controlled clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050589
Enrollment
60
Registered
2023-03-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: Qurs-e-kakanaj: drug will be given 2 tab thrice a day for 14 days after food with plenty of water Control Intervention1: Tab Ofloxacin (400mg): drug will be given 1 tab once a day for 1

Sponsors

Department of Moalejat Ajmal Khan Tibbiya college AMU AligarhIiya C
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients from 20-60 years of age of both sexes. Clinically diagnosed patients of UTI with the help of subjectve and objective parameters. Patients who give informed consent. Subjective parameters - Dysurea, Frequency of micturition, Fever with or without chills, Suprapubic pain. Objective parameters- CBC with ESR, Urine (Routine and Microscopic)

Exclusion criteria

Exclusion criteria: Patients below 20 years and above 60 years of age. Pregnant and lactating mothers. Patients with Diabetes Mellitus, renal faillure or CKD and Obstructive Uropathy. Patients suffering from any congenital abnormality of Urinary Tract. Patients who fail to give consent and fail to follow up. Patients who have been taken prior antibiotics for Patients with evidence of severe UTI and mentally retarded patients.

Design outcomes

Primary

MeasureTime frame
Improvement in Objective parametrs. Urine (RM)- At baseline and end of the study. (To look for Pus cells) CBC with ESR- At baseline and at the end of the study (To look for Total leucocyte count) Timepoint: 14 days with follow up weekly for 3 weeks CBC with ESR and Urine RM will be done at baseline and at the end of the study.—

Secondary

MeasureTime frame
Improvement in Subjective parameters.Timepoint: 14 days with follow up weekly for 3 weeks Every visit (weekly) patients will be assessed on the basis of improvement and worsening in subjective parameters. Improvement in Dysurea, fever , suprapubic pain.—

Countries

India

Contacts

Public ContactNishat Afroz

Department of Moalejat Ajmal Khan Tibbiya College AMU Aligarh

drbdkhanamu@gmail.com9412333174

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026